The publisher of Dickinsonís FDA Webview is Ferdic, Incorporated, a 1982-established
company founded and continuously led by James G. Dickinson, who first began reporting
and analyzing FDA news in 1975 at FDC Reports, Inc., publisher of the Pink Sheet and
other trade newsletters. Two years later, while still at FDC Reports, Dickinson came
under the notice of other publishers and was soon supplying his analytical reports
about FDA and related Washington activities to Drug Topics, Scrip World Pharmaceutical
News (UK), Pharmaceutical Technology, Pharmaceutical Executive, the Pharmaceutical
Journal (UK), Clinica (UK), Animal Pharm (UK), the Australian Journal of Pharmacy,
New Zealand Pharmacy, Drug News & Perspectives (Spain), Medical Device & Diagnostic
Industry, and Medical Marketing & Media.

In 1978, Dickinson conceived the idea upon which FDA Webview would later be based,
establishing the first daily FDA news service for the pharmaceutical industry in
Washington Drugwire. Ahead of its time, this was a daily single-sheet Western Union
Mailgram providing between five and eight specialized news capsules each morning,
based on Dickinsonís exclusive FDA sources. The service was too expensive, however,
and it ceased publication the following year.

Dickinson consolidated his many journalistic activities in 1982 under an independent
company he established with his wife, the former Sheila Ferguson (Ferdic is a combination
of their two last names), and in 1984 they launched the twice-monthly Dickinsonís FDA, a
unique analytical newsletter covering FDA regulation of pharmaceuticals, medical devices,
biologics and veterinary medicines. followed by Dickinsonís Pharmacy and Dickinsonís PSAO (two pharmacy-oriented monthlies).

In 1992, the company launched Dickinsonís FDA Inspection, a monthly newsletter focussing
on in-depth analysis of FDA enforcement and compliance actions, co-edited with a former FDA
prescription drug labeling compliance director, Rudolf Apodaca. In 1993, this publication
was merged with Dickinsonís FDA in a new monthly, Dickinsonís FDA Review, with former FDA
Denver District director John Scharmann as consulting editor.

Today Dickinson continues as Editor, Publisher and President of Ferdic, Inc, which has a staff of writers, researchers and office personnel under the direction of Washington Editor David McFarland.